Incision and drainage: Difference between revisions
(Updated format to procedure-centric) |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Check: Blood Glucose, IV drug use (XR r/o needle), consider HIV counseling/testing | |||
== | ==Indications== | ||
== | ==Contraindications== | ||
==Procedure== | |||
===Anesthesia=== | |||
{{Maximum doses of anesthetic agents}} | {{Maximum doses of anesthetic agents}} | ||
===Post-procedure=== | |||
*[[Antibiotics]] only indicated if overlying cellulitis or evidence of systemic infection | |||
**Cover [[staph]] and [[strep]] | |||
*Update [[Tetanus]], if indicated | |||
==Follow-up== | ==Follow-up== | ||
| Line 32: | Line 25: | ||
*[[Bartholin Gland Abscess]] | *[[Bartholin Gland Abscess]] | ||
== | ==References== | ||
<references/> | |||
*Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-e55 | *Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-e55 | ||
*Singer A, Talan D. Management of Skin Abscesses in the Era of Methicillin-Resistant Staphylococcus aureus. N Engl J Med 2014; 370:1039-1047 | *Singer A, Talan D. Management of Skin Abscesses in the Era of Methicillin-Resistant Staphylococcus aureus. N Engl J Med 2014; 370:1039-1047 | ||
Revision as of 10:37, 21 June 2015
Background
- Check: Blood Glucose, IV drug use (XR r/o needle), consider HIV counseling/testing
Indications
Contraindications
Procedure
Anesthesia
Maximum Doses of Anesthetic Agents
| Agent | Without Epinephrine | With Epinephrine | Duration | Notes |
| Lidocaine | 5 mg/kg (max 300mg) | 7 mg/kg (max 500mg) | 30-90 min |
|
| Mepivicaine | 7 mg/kg | 8 mg/kg | ||
| Bupivicaine | 2.5 mg/kg (max 175mg) | 3 mg/kg (max 225mg) | 6-8 hr |
|
| Ropivacaine | 3 mg/kg | |||
| Prilocaine | 6 mg/kg | |||
| Tetracaine | 1 mg/kg | 1.5 mg/kg | 3hrs (10hrs with epi) | |
| Procaine | 7 mg/kg | 10 mg/kg | 30min (90min with epi) |
Post-procedure
- Antibiotics only indicated if overlying cellulitis or evidence of systemic infection
- Update Tetanus, if indicated
Follow-up
Wound check in 1-2 days and wound care sheet
See Also
References
- Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-e55
- Singer A, Talan D. Management of Skin Abscesses in the Era of Methicillin-Resistant Staphylococcus aureus. N Engl J Med 2014; 370:1039-1047